Skip to main content

Soft Tissue Sarcoma News

Related terms: Alveolar rhabdomyosarcoma, Cancer, Rhabdomyosarcoma, Cancer, Soft Tissue Sarcoma, Embryonal rhabdomyosarcoma, Sarcoma botryoides

Immunotherapy Before Sarcoma Surgery Improves Outcomes

Immunotherapy can improve outcomes in patients undergoing surgery for soft-tissue sarcoma Immunotherapy and radiation therapy prior to surgery led to 90% of patients having nearly all cancer...

Coexisting Conditions Impact Survival in Oral Cancer

WEDNESDAY, July 12, 2023 – For patients with oral squamous cell carcinoma, excluding the effects of coexisting conditions can lead to underestimation or overestimation of survival, according to a...

FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma

October 19, 2016 – The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS),...

FDA Approves Halaven (eribulin mesylate) for the Treatment of Liposarcoma

January 28, 2016 – The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma)...

FDA Approves Yondelis (trabectedin) for the Treatment of Specific Soft Tissue Sarcomas

October 23, 2015 - The U.S. Food and Drug Administration today approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific soft tissue sarcomas (STS) – liposarcoma and l...

FDA Approves Votrient for Advanced Soft Tissue Sarcoma

April 26, 2012 – The U.S. Food and Drug Administration today approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously received chemotherapy. Soft tissue...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cancer

Related drug support groups

methotrexate